Editorial: Is it time to start with device-based prognosticators?

Europace

Volumn 12, Issue 1, 2010, Pages 7-8

  Auricchio, Angelo ^a  

^a DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR SYSTEM EXAMINATION; COMORBIDITY; COMPUTER ASSISTED DIAGNOSIS; DEFIBRILLATOR; DEMOGRAPHY; DEVICE THERAPY; EDITORIAL; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; LONG TERM CARE; PRIORITY JOURNAL; RISK FACTOR; RR INTERVAL; SEX DIFFERENCE; AGED; DECISION SUPPORT SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; HEART PACING; HUMAN; INCIDENCE; MALE; METHODOLOGY; MORTALITY; NOTE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

AGED; CARDIAC PACING, ARTIFICIAL; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 73849150110     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup291     Document Type: Editorial

References (9)

1. Singh JP, Rosenthal LS, Hranitzky PM, Berg KC, Mullin CM, Thackeray L et al. Device diagnostics and long term clinical outcome in patients receiving cardiac resynchronization therapy. Europace 2009;11:1647-1653
2. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003;108:266-269
3. Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J et al. Cardiac resynchronization therapy improbe heart rate profile and heart rate variabilità in patients with moderate to severe heart failure. J Am Coll Cardiol 2005;46:1875-1882
4. Gilliam FR III, Kaplan AJ, Black J, Chase KJ, Mullin CM. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry. Pacing Clin Electrophysiol 2007;30:56-64.
5. Myerburg RJ, Reddy V, Castellanos A. Indications for implantable cardioverterdefibrillators based on evidence and judgment. J Am Coll Cardiol 2009;54:747-763
6. Whellan DJ, O'Connor CM, Ousdigian KT, Lung TH on behalf of PARTNERS HF Study Investigators. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). Am Heart J 2008;156:833-839
7. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J et al. on behalf of DOT-HF steering committee and Investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail 2008;10:907-916
8. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S et al. Utility of the Seattle heart failure model in patients with advanced heart failure. J Am Coll Cardiol 2009;53:334-342
9. Moss AJ, Hall WJ, Cannom DS, Klein H, Briwn MW, Daubert JP et al. for the MADIT-CRT Investigators. Cardiac resynchronization therapy for prevention of heart failure events. N Engl J Med 2009;361:1-10.